"Factor XIII" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A fibrin-stabilizing plasma enzyme (TRANSGLUTAMINASES) that is activated by THROMBIN and CALCIUM to form FACTOR XIIIA. It is important for stabilizing the formation of the fibrin polymer (clot) which culminates the coagulation cascade.
Descriptor ID |
D005176
|
MeSH Number(s) |
D12.776.124.125.475 D23.119.475
|
Concept/Terms |
Factor XIII- Factor XIII
- Factor Thirteen
- Coagulation Factor XIII
- Factor XIII, Coagulation
- XIII, Coagulation Factor
- Factor XIII Transamidase
- Transamidase, Factor XIII
- Fibrinase
- Laki Lorand Factor
- Laki-Lorand Factor
- Blood Coagulation Factor XIII
- Factor 13
- Fibrin Stabilizing Factor
- Stabilizing Factor, Fibrin
|
Below are MeSH descriptors whose meaning is more general than "Factor XIII".
Below are MeSH descriptors whose meaning is more specific than "Factor XIII".
This graph shows the total number of publications written about "Factor XIII" by people in this website by year, and whether "Factor XIII" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 0 | 1 | 1 |
2005 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2022 | 0 | 1 | 1 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Factor XIII" by people in Profiles.
-
Traumatic intracranial hemorrhage in pediatrics: Implications of factor XIII deficiency and consumptive coagulopathy in abusive head trauma evaluation. Child Abuse Negl. 2024 03; 149:106651.
-
Factor XIII levels, clot strength, and impact of fibrinogen concentrate in infants undergoing cardiopulmonary bypass: a mechanistic sub-study of the FIBCON trial. Br J Anaesth. 2023 02; 130(2):175-182.
-
Factor XIII Subunit A Immunohistochemical Expression is Associated With Inferior Outcomes in Acute Promyelocytic Leukemia. Appl Immunohistochem Mol Morphol. 2018 Mar; 26(3):202-205.
-
Use of factor concentrates for the management of perioperative bleeding: guidance from the SSC of the ISTH. J Thromb Haemost. 2018 01; 16(1):170-174.
-
Impaired Activity of Blood Coagulant Factor XIII in Patients with Necrotizing Enterocolitis. Sci Rep. 2015 Aug 17; 5:13119.
-
Near-infrared fluorescent imaging of cerebral thrombi and blood-brain barrier disruption in a mouse model of cerebral venous sinus thrombosis. J Cereb Blood Flow Metab. 2005 Feb; 25(2):226-33.
-
"Juvenile" xanthogranuloma: an immunophenotypic study with a reappraisal of histogenesis. Am J Dermatopathol. 2001 Apr; 23(2):104-11.
-
Extensive DNA polymorphism at the factor XIIIa (F13A) locus and linkage to HLA. Am J Hum Genet. 1988 Jun; 42(6):877-83.
-
Life salvage with fibrin glue in three cases of exsanguinating hemorrhage. Can J Surg. 1986 May; 29(3):214-5, 217.